New hope for hard-to-treat blood cancers? early trial tests DSP107 combo
Disease control
Terminated
This early-phase study tested a new drug called DSP107 combined with standard chemotherapy for people with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML) that had come back or not responded to prior treatments. The goal was…
Phase: PHASE1 • Sponsor: Kahr Medical • Aim: Disease control
Last updated May 01, 2026 16:01 UTC